Hologic Inc. develops, manufactures, and supplies diagnostics, medical imaging systems and surgical products which cater to the healthcare needs of women. Hologic operates through the following four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health.
| Revenue (Most Recent Fiscal Year) | $4.03B |
| Net Income (Most Recent Fiscal Year) | $789.50M |
| PE Ratio (Current Year Earnings Estimate) | 13.59 |
| PE Ratio (Trailing 12 Months) | 14.05 |
| PEG Ratio (Long Term Growth Estimate) | 1.98 |
| Price to Sales Ratio (Trailing 12 Months) | 3.22 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 2.74 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 10.55 |
| Pre-Tax Margin (Trailing 12 Months) | 22.81% |
| Net Margin (Trailing 12 Months) | 18.42% |
| Return on Equity (Trailing 12 Months) | 19.72% |
| Return on Assets (Trailing 12 Months) | 10.94% |
| Current Ratio (Most Recent Fiscal Quarter) | 3.49 |
| Quick Ratio (Most Recent Fiscal Quarter) | 2.78 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.52 |
| Inventory Turnover (Trailing 12 Months) | 2.66 |
| Book Value per Share (Most Recent Fiscal Quarter) | $22.09 |
| Earnings per Share (Most Recent Fiscal Quarter) | $1.03 |
| Earnings per Share (Most Recent Fiscal Year) | $4.08 |
| Diluted Earnings per Share (Trailing 12 Months) | $3.17 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Common Shares Outstanding | 224.39M |
| Free Float | 220.17M |
| Market Capitalization | $13.02B |
| Average Volume (Last 20 Days) | 3.40M |
| Beta (Past 60 Months) | 0.82 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 1.88% |
| Percentage Held By Institutions (Latest 13F Reports) | 94.73% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |